Alzheimer is a chronic neurodegenerative disease that usually starts slowly and gradually worsens over time. Parkinson is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.

Market Analysis and Insights: Global Alzheimers and Parkinsons Diseases Market

The global Alzheimers and Parkinsons Diseases market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Alzheimers and Parkinsons Diseases is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Alzheimers and Parkinsons Diseases is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Alzheimers and Parkinsons Diseases is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Alzheimers and Parkinsons Diseases include Hoffmann-La Roche, Novartis, Pfizer, Merck, Eli Lilly, Orion Pharma, UCB, AstraZeneca and Biogen, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Alzheimers and Parkinsons Diseases is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Alzheimers and Parkinsons Diseases industry development. In 2023, global % revenue of Alzheimers and Parkinsons Diseases went into Hospital filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Alzheimers and Parkinsons Diseases market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Alzheimers and Parkinsons Diseases, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Alzheimers and Parkinsons Diseases, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alzheimers and Parkinsons Diseases revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Alzheimers and Parkinsons Diseases market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Alzheimers and Parkinsons Diseases revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Alzheimers and Parkinsons Diseases Market Report

Report Metric	Details
Report Name	Alzheimers and Parkinsons Diseases Market
Segment by Type	Alzheimers Parkinsons
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Hoffmann-La Roche, Novartis, Pfizer, Merck, Eli Lilly, Orion Pharma, UCB, AstraZeneca, Biogen, Teva Pharmaceutical Industries, AbbVie, Vertical Pharmaceuticals, ALLERGAN, ACADIA Pharmaceuticals, Impax Laboratories, GE healthcare, VTV Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Alzheimers and Parkinsons Diseases in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimers and Parkinsons Diseases companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alzheimers and Parkinsons Diseases revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Alzheimers and Parkinsons Diseases Market report?

Ans: The main players in the Alzheimers and Parkinsons Diseases Market are Hoffmann-La Roche, Novartis, Pfizer, Merck, Eli Lilly, Orion Pharma, UCB, AstraZeneca, Biogen, Teva Pharmaceutical Industries, AbbVie, Vertical Pharmaceuticals, ALLERGAN, ACADIA Pharmaceuticals, Impax Laboratories, GE healthcare, VTV Therapeutics

What are the Application segmentation covered in the Alzheimers and Parkinsons Diseases Market report?

Ans: The Applications covered in the Alzheimers and Parkinsons Diseases Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Alzheimers and Parkinsons Diseases Market report?

Ans: The Types covered in the Alzheimers and Parkinsons Diseases Market report are Alzheimers, Parkinsons

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Alzheimers and Parkinsons Diseases Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Alzheimers

1.2.3 Parkinsons

1.3 Market by Application

1.3.1 Global Alzheimers and Parkinsons Diseases Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Alzheimers and Parkinsons Diseases Market Perspective (2019-2030)

2.2 Global Alzheimers and Parkinsons Diseases Growth Trends by Region

2.2.1 Alzheimers and Parkinsons Diseases Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Alzheimers and Parkinsons Diseases Historic Market Size by Region (2019-2024)

2.2.3 Alzheimers and Parkinsons Diseases Forecasted Market Size by Region (2025-2030)

2.3 Alzheimers and Parkinsons Diseases Market Dynamics

2.3.1 Alzheimers and Parkinsons Diseases Industry Trends

2.3.2 Alzheimers and Parkinsons Diseases Market Drivers

2.3.3 Alzheimers and Parkinsons Diseases Market Challenges

2.3.4 Alzheimers and Parkinsons Diseases Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Alzheimers and Parkinsons Diseases by Players

3.1.1 Global Alzheimers and Parkinsons Diseases Revenue by Players (2019-2024)

3.1.2 Global Alzheimers and Parkinsons Diseases Revenue Market Share by Players (2019-2024)

3.2 Global Alzheimers and Parkinsons Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Alzheimers and Parkinsons Diseases, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Alzheimers and Parkinsons Diseases Market Concentration Ratio

3.4.1 Global Alzheimers and Parkinsons Diseases Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Alzheimers and Parkinsons Diseases Revenue in 2023

3.5 Global Key Players of Alzheimers and Parkinsons Diseases Head office and Area Served

3.6 Global Key Players of Alzheimers and Parkinsons Diseases, Product and Application

3.7 Global Key Players of Alzheimers and Parkinsons Diseases, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Alzheimers and Parkinsons Diseases Breakdown Data by Type

4.1 Global Alzheimers and Parkinsons Diseases Historic Market Size by Type (2019-2024)

4.2 Global Alzheimers and Parkinsons Diseases Forecasted Market Size by Type (2025-2030)

5 Alzheimers and Parkinsons Diseases Breakdown Data by Application

5.1 Global Alzheimers and Parkinsons Diseases Historic Market Size by Application (2019-2024)

5.2 Global Alzheimers and Parkinsons Diseases Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Alzheimers and Parkinsons Diseases Market Size (2019-2030)

6.2 North America Alzheimers and Parkinsons Diseases Market Size by Type

6.2.1 North America Alzheimers and Parkinsons Diseases Market Size by Type (2019-2024)

6.2.2 North America Alzheimers and Parkinsons Diseases Market Size by Type (2025-2030)

6.2.3 North America Alzheimers and Parkinsons Diseases Market Share by Type (2019-2030)

6.3 North America Alzheimers and Parkinsons Diseases Market Size by Application

6.3.1 North America Alzheimers and Parkinsons Diseases Market Size by Application (2019-2024)

6.3.2 North America Alzheimers and Parkinsons Diseases Market Size by Application (2025-2030)

6.3.3 North America Alzheimers and Parkinsons Diseases Market Share by Application (2019-2030)

6.4 North America Alzheimers and Parkinsons Diseases Market Size by Country

6.4.1 North America Alzheimers and Parkinsons Diseases Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Alzheimers and Parkinsons Diseases Market Size by Country (2019-2024)

6.4.3 North America Alzheimers and Parkinsons Diseases Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Alzheimers and Parkinsons Diseases Market Size (2019-2030)

7.2 Europe Alzheimers and Parkinsons Diseases Market Size by Type

7.2.1 Europe Alzheimers and Parkinsons Diseases Market Size by Type (2019-2024)

7.2.2 Europe Alzheimers and Parkinsons Diseases Market Size by Type (2025-2030)

7.2.3 Europe Alzheimers and Parkinsons Diseases Market Share by Type (2019-2030)

7.3 Europe Alzheimers and Parkinsons Diseases Market Size by Application

7.3.1 Europe Alzheimers and Parkinsons Diseases Market Size by Application (2019-2024)

7.3.2 Europe Alzheimers and Parkinsons Diseases Market Size by Application (2025-2030)

7.3.3 Europe Alzheimers and Parkinsons Diseases Market Share by Application (2019-2030)

7.4 Europe Alzheimers and Parkinsons Diseases Market Size by Country

7.4.1 Europe Alzheimers and Parkinsons Diseases Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Alzheimers and Parkinsons Diseases Market Size by Country (2019-2024)

7.4.3 Europe Alzheimers and Parkinsons Diseases Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Alzheimers and Parkinsons Diseases Market Size (2019-2030)

8.2 China Alzheimers and Parkinsons Diseases Market Size by Type

8.2.1 China Alzheimers and Parkinsons Diseases Market Size by Type (2019-2024)

8.2.2 China Alzheimers and Parkinsons Diseases Market Size by Type (2025-2030)

8.2.3 China Alzheimers and Parkinsons Diseases Market Share by Type (2019-2030)

8.3 China Alzheimers and Parkinsons Diseases Market Size by Application

8.3.1 China Alzheimers and Parkinsons Diseases Market Size by Application (2019-2024)

8.3.2 China Alzheimers and Parkinsons Diseases Market Size by Application (2025-2030)

8.3.3 China Alzheimers and Parkinsons Diseases Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Alzheimers and Parkinsons Diseases Market Size (2019-2030)

9.2 Asia Alzheimers and Parkinsons Diseases Market Size by Type

9.2.1 Asia Alzheimers and Parkinsons Diseases Market Size by Type (2019-2024)

9.2.2 Asia Alzheimers and Parkinsons Diseases Market Size by Type (2025-2030)

9.2.3 Asia Alzheimers and Parkinsons Diseases Market Share by Type (2019-2030)

9.3 Asia Alzheimers and Parkinsons Diseases Market Size by Application

9.3.1 Asia Alzheimers and Parkinsons Diseases Market Size by Application (2019-2024)

9.3.2 Asia Alzheimers and Parkinsons Diseases Market Size by Application (2025-2030)

9.3.3 Asia Alzheimers and Parkinsons Diseases Market Share by Application (2019-2030)

9.4 Asia Alzheimers and Parkinsons Diseases Market Size by Region

9.4.1 Asia Alzheimers and Parkinsons Diseases Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Alzheimers and Parkinsons Diseases Market Size by Region (2019-2024)

9.4.3 Asia Alzheimers and Parkinsons Diseases Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Type

10.2.1 Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Application

10.3.1 Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Country

10.4.1 Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Hoffmann-La Roche

11.1.1 Hoffmann-La Roche Company Details

11.1.2 Hoffmann-La Roche Business Overview

11.1.3 Hoffmann-La Roche Alzheimers and Parkinsons Diseases Introduction

11.1.4 Hoffmann-La Roche Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.1.5 Hoffmann-La Roche Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Alzheimers and Parkinsons Diseases Introduction

11.2.4 Novartis Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.2.5 Novartis Recent Developments

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Alzheimers and Parkinsons Diseases Introduction

11.3.4 Pfizer Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.3.5 Pfizer Recent Developments

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Alzheimers and Parkinsons Diseases Introduction

11.4.4 Merck Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.4.5 Merck Recent Developments

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Alzheimers and Parkinsons Diseases Introduction

11.5.4 Eli Lilly Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.5.5 Eli Lilly Recent Developments

11.6 Orion Pharma

11.6.1 Orion Pharma Company Details

11.6.2 Orion Pharma Business Overview

11.6.3 Orion Pharma Alzheimers and Parkinsons Diseases Introduction

11.6.4 Orion Pharma Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.6.5 Orion Pharma Recent Developments

11.7 UCB

11.7.1 UCB Company Details

11.7.2 UCB Business Overview

11.7.3 UCB Alzheimers and Parkinsons Diseases Introduction

11.7.4 UCB Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.7.5 UCB Recent Developments

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Alzheimers and Parkinsons Diseases Introduction

11.8.4 AstraZeneca Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.8.5 AstraZeneca Recent Developments

11.9 Biogen

11.9.1 Biogen Company Details

11.9.2 Biogen Business Overview

11.9.3 Biogen Alzheimers and Parkinsons Diseases Introduction

11.9.4 Biogen Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.9.5 Biogen Recent Developments

11.10 Teva Pharmaceutical Industries

11.10.1 Teva Pharmaceutical Industries Company Details

11.10.2 Teva Pharmaceutical Industries Business Overview

11.10.3 Teva Pharmaceutical Industries Alzheimers and Parkinsons Diseases Introduction

11.10.4 Teva Pharmaceutical Industries Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.10.5 Teva Pharmaceutical Industries Recent Developments

11.11 AbbVie

11.11.1 AbbVie Company Details

11.11.2 AbbVie Business Overview

11.11.3 AbbVie Alzheimers and Parkinsons Diseases Introduction

11.11.4 AbbVie Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.11.5 AbbVie Recent Developments

11.12 Vertical Pharmaceuticals

11.12.1 Vertical Pharmaceuticals Company Details

11.12.2 Vertical Pharmaceuticals Business Overview

11.12.3 Vertical Pharmaceuticals Alzheimers and Parkinsons Diseases Introduction

11.12.4 Vertical Pharmaceuticals Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.12.5 Vertical Pharmaceuticals Recent Developments

11.13 ALLERGAN

11.13.1 ALLERGAN Company Details

11.13.2 ALLERGAN Business Overview

11.13.3 ALLERGAN Alzheimers and Parkinsons Diseases Introduction

11.13.4 ALLERGAN Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.13.5 ALLERGAN Recent Developments

11.14 ACADIA Pharmaceuticals

11.14.1 ACADIA Pharmaceuticals Company Details

11.14.2 ACADIA Pharmaceuticals Business Overview

11.14.3 ACADIA Pharmaceuticals Alzheimers and Parkinsons Diseases Introduction

11.14.4 ACADIA Pharmaceuticals Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.14.5 ACADIA Pharmaceuticals Recent Developments

11.15 Impax Laboratories

11.15.1 Impax Laboratories Company Details

11.15.2 Impax Laboratories Business Overview

11.15.3 Impax Laboratories Alzheimers and Parkinsons Diseases Introduction

11.15.4 Impax Laboratories Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.15.5 Impax Laboratories Recent Developments

11.16 GE healthcare

11.16.1 GE healthcare Company Details

11.16.2 GE healthcare Business Overview

11.16.3 GE healthcare Alzheimers and Parkinsons Diseases Introduction

11.16.4 GE healthcare Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.16.5 GE healthcare Recent Developments

11.17 VTV Therapeutics

11.17.1 VTV Therapeutics Company Details

11.17.2 VTV Therapeutics Business Overview

11.17.3 VTV Therapeutics Alzheimers and Parkinsons Diseases Introduction

11.17.4 VTV Therapeutics Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024)

11.17.5 VTV Therapeutics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Teva Pharmaceutical Industries

AbbVie

Vertical Pharmaceuticals

Allergan plc

ACADIA Pharmaceuticals

Impax Laboratories

GE Healthcare

VTV Therapeutics

List of Tables

Table 1. Global Alzheimers and Parkinsons Diseases Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Alzheimers

Table 3. Key Players of Parkinsons

Table 4. Global Alzheimers and Parkinsons Diseases Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Alzheimers and Parkinsons Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Alzheimers and Parkinsons Diseases Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Alzheimers and Parkinsons Diseases Market Share by Region (2019-2024)

Table 8. Global Alzheimers and Parkinsons Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Alzheimers and Parkinsons Diseases Market Share by Region (2025-2030)

Table 10. Alzheimers and Parkinsons Diseases Market Trends

Table 11. Alzheimers and Parkinsons Diseases Market Drivers

Table 12. Alzheimers and Parkinsons Diseases Market Challenges

Table 13. Alzheimers and Parkinsons Diseases Market Restraints

Table 14. Global Alzheimers and Parkinsons Diseases Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Alzheimers and Parkinsons Diseases Revenue Share by Players (2019-2024)

Table 16. Global Top Alzheimers and Parkinsons Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimers and Parkinsons Diseases as of 2023)

Table 17. Global Alzheimers and Parkinsons Diseases Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Alzheimers and Parkinsons Diseases Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Alzheimers and Parkinsons Diseases, Headquarters and Area Served

Table 20. Global Key Players of Alzheimers and Parkinsons Diseases, Product and Application

Table 21. Global Key Players of Alzheimers and Parkinsons Diseases, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Alzheimers and Parkinsons Diseases Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Alzheimers and Parkinsons Diseases Revenue Market Share by Type (2019-2024)

Table 25. Global Alzheimers and Parkinsons Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Alzheimers and Parkinsons Diseases Revenue Market Share by Type (2025-2030)

Table 27. Global Alzheimers and Parkinsons Diseases Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Alzheimers and Parkinsons Diseases Revenue Share by Application (2019-2024)

Table 29. Global Alzheimers and Parkinsons Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Alzheimers and Parkinsons Diseases Revenue Share by Application (2025-2030)

Table 31. North America Alzheimers and Parkinsons Diseases Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Alzheimers and Parkinsons Diseases Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Alzheimers and Parkinsons Diseases Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Alzheimers and Parkinsons Diseases Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Alzheimers and Parkinsons Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Alzheimers and Parkinsons Diseases Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Alzheimers and Parkinsons Diseases Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Alzheimers and Parkinsons Diseases Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Alzheimers and Parkinsons Diseases Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Alzheimers and Parkinsons Diseases Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Alzheimers and Parkinsons Diseases Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Alzheimers and Parkinsons Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Alzheimers and Parkinsons Diseases Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Alzheimers and Parkinsons Diseases Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Alzheimers and Parkinsons Diseases Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Alzheimers and Parkinsons Diseases Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Alzheimers and Parkinsons Diseases Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Alzheimers and Parkinsons Diseases Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Alzheimers and Parkinsons Diseases Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Alzheimers and Parkinsons Diseases Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Alzheimers and Parkinsons Diseases Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Alzheimers and Parkinsons Diseases Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Alzheimers and Parkinsons Diseases Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Alzheimers and Parkinsons Diseases Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Alzheimers and Parkinsons Diseases Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size by Country (2025-2030) & (US$ Million)

Table 63. Hoffmann-La Roche Company Details

Table 64. Hoffmann-La Roche Business Overview

Table 65. Hoffmann-La Roche Alzheimers and Parkinsons Diseases Product

Table 66. Hoffmann-La Roche Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 67. Hoffmann-La Roche Recent Developments

Table 68. Novartis Company Details

Table 69. Novartis Business Overview

Table 70. Novartis Alzheimers and Parkinsons Diseases Product

Table 71. Novartis Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 72. Novartis Recent Developments

Table 73. Pfizer Company Details

Table 74. Pfizer Business Overview

Table 75. Pfizer Alzheimers and Parkinsons Diseases Product

Table 76. Pfizer Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 77. Pfizer Recent Developments

Table 78. Merck Company Details

Table 79. Merck Business Overview

Table 80. Merck Alzheimers and Parkinsons Diseases Product

Table 81. Merck Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 82. Merck Recent Developments

Table 83. Eli Lilly Company Details

Table 84. Eli Lilly Business Overview

Table 85. Eli Lilly Alzheimers and Parkinsons Diseases Product

Table 86. Eli Lilly Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 87. Eli Lilly Recent Developments

Table 88. Orion Pharma Company Details

Table 89. Orion Pharma Business Overview

Table 90. Orion Pharma Alzheimers and Parkinsons Diseases Product

Table 91. Orion Pharma Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 92. Orion Pharma Recent Developments

Table 93. UCB Company Details

Table 94. UCB Business Overview

Table 95. UCB Alzheimers and Parkinsons Diseases Product

Table 96. UCB Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 97. UCB Recent Developments

Table 98. AstraZeneca Company Details

Table 99. AstraZeneca Business Overview

Table 100. AstraZeneca Alzheimers and Parkinsons Diseases Product

Table 101. AstraZeneca Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 102. AstraZeneca Recent Developments

Table 103. Biogen Company Details

Table 104. Biogen Business Overview

Table 105. Biogen Alzheimers and Parkinsons Diseases Product

Table 106. Biogen Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 107. Biogen Recent Developments

Table 108. Teva Pharmaceutical Industries Company Details

Table 109. Teva Pharmaceutical Industries Business Overview

Table 110. Teva Pharmaceutical Industries Alzheimers and Parkinsons Diseases Product

Table 111. Teva Pharmaceutical Industries Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 112. Teva Pharmaceutical Industries Recent Developments

Table 113. AbbVie Company Details

Table 114. AbbVie Business Overview

Table 115. AbbVie Alzheimers and Parkinsons Diseases Product

Table 116. AbbVie Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 117. AbbVie Recent Developments

Table 118. Vertical Pharmaceuticals Company Details

Table 119. Vertical Pharmaceuticals Business Overview

Table 120. Vertical Pharmaceuticals Alzheimers and Parkinsons Diseases Product

Table 121. Vertical Pharmaceuticals Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 122. Vertical Pharmaceuticals Recent Developments

Table 123. ALLERGAN Company Details

Table 124. ALLERGAN Business Overview

Table 125. ALLERGAN Alzheimers and Parkinsons Diseases Product

Table 126. ALLERGAN Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 127. ALLERGAN Recent Developments

Table 128. ACADIA Pharmaceuticals Company Details

Table 129. ACADIA Pharmaceuticals Business Overview

Table 130. ACADIA Pharmaceuticals Alzheimers and Parkinsons Diseases Product

Table 131. ACADIA Pharmaceuticals Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 132. ACADIA Pharmaceuticals Recent Developments

Table 133. Impax Laboratories Company Details

Table 134. Impax Laboratories Business Overview

Table 135. Impax Laboratories Alzheimers and Parkinsons Diseases Product

Table 136. Impax Laboratories Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 137. Impax Laboratories Recent Developments

Table 138. GE healthcare Company Details

Table 139. GE healthcare Business Overview

Table 140. GE healthcare Alzheimers and Parkinsons Diseases Product

Table 141. GE healthcare Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 142. GE healthcare Recent Developments

Table 143. VTV Therapeutics Company Details

Table 144. VTV Therapeutics Business Overview

Table 145. VTV Therapeutics Alzheimers and Parkinsons Diseases Product

Table 146. VTV Therapeutics Revenue in Alzheimers and Parkinsons Diseases Business (2019-2024) & (US$ Million)

Table 147. VTV Therapeutics Recent Developments

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Alzheimers and Parkinsons Diseases Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Alzheimers and Parkinsons Diseases Market Share by Type: 2023 VS 2030

Figure 3. Alzheimers Features

Figure 4. Parkinsons Features

Figure 5. Global Alzheimers and Parkinsons Diseases Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Alzheimers and Parkinsons Diseases Market Share by Application: 2023 VS 2030

Figure 7. Hospital Case Studies

Figure 8. Clinic Case Studies

Figure 9. Other Case Studies

Figure 10. Alzheimers and Parkinsons Diseases Report Years Considered

Figure 11. Global Alzheimers and Parkinsons Diseases Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Alzheimers and Parkinsons Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Alzheimers and Parkinsons Diseases Market Share by Region: 2023 VS 2030

Figure 14. Global Alzheimers and Parkinsons Diseases Market Share by Players in 2023

Figure 15. Global Top Alzheimers and Parkinsons Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimers and Parkinsons Diseases as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Alzheimers and Parkinsons Diseases Revenue in 2023

Figure 17. North America Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Alzheimers and Parkinsons Diseases Market Share by Type (2019-2030)

Figure 19. North America Alzheimers and Parkinsons Diseases Market Share by Application (2019-2030)

Figure 20. North America Alzheimers and Parkinsons Diseases Market Share by Country (2019-2030)

Figure 21. United States Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Alzheimers and Parkinsons Diseases Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Alzheimers and Parkinsons Diseases Market Share by Type (2019-2030)

Figure 25. Europe Alzheimers and Parkinsons Diseases Market Share by Application (2019-2030)

Figure 26. Europe Alzheimers and Parkinsons Diseases Market Share by Country (2019-2030)

Figure 27. Germany Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Alzheimers and Parkinsons Diseases Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Alzheimers and Parkinsons Diseases Market Share by Type (2019-2030)

Figure 35. China Alzheimers and Parkinsons Diseases Market Share by Application (2019-2030)

Figure 36. Asia Alzheimers and Parkinsons Diseases Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Alzheimers and Parkinsons Diseases Market Share by Type (2019-2030)

Figure 38. Asia Alzheimers and Parkinsons Diseases Market Share by Application (2019-2030)

Figure 39. Asia Alzheimers and Parkinsons Diseases Market Share by Region (2019-2030)

Figure 40. Japan Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Alzheimers and Parkinsons Diseases Market Share by Country (2019-2030)

Figure 50. Brazil Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Alzheimers and Parkinsons Diseases Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Hoffmann-La Roche Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 57. Novartis Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 58. Pfizer Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 59. Merck Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 60. Eli Lilly Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 61. Orion Pharma Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 62. UCB Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 63. AstraZeneca Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 64. Biogen Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 65. Teva Pharmaceutical Industries Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 66. AbbVie Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 67. Vertical Pharmaceuticals Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 68. ALLERGAN Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 69. ACADIA Pharmaceuticals Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 70. Impax Laboratories Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 71. GE healthcare Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 72. VTV Therapeutics Revenue Growth Rate in Alzheimers and Parkinsons Diseases Business (2019-2024)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Alzheimer s Disease Drug Market Insights Forecast to 2030

Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Alzheimer s Disease Treatments Market Research Report 2024

Global Alzheimer Treatment Drug Market Research Report 2025

Dementia and Alzheimer s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Parkinson s Disease Therapeutics Market Research Report 2025

Global Parkinson s Disease Treatment Market Insights Forecast to 2030

Global Neurodegenerative Disease Treatment Market Research Report 2024

Rare Neurodegenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neurological Biomarkers for Alzheimer s and Parkinson s Diseases Market Research Report 2025

Neurodegenerative Diseases Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Parkinson Disease Drug Market Insights Forecast to 2030

Global Anti Parkinson Drugs Market Insights Forecast to 2030

Global Neurodegenerative Disorder Therapeutics Market Research Report 2024

Global Alzheimer s Disease Blood Test Kit Market Research Report 2024

Global Blood based Detection Kit for Early Diagnosis of Alzheimer s Disease Market Research Report 2024

Global Parkinsons Disease Drug Market Insights Forecast to 2030

Global Central Nervous System Biomarkers Market Insights Forecast to 2030

Alzheimer Disease Genetic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions